I recently came across a report by Roots Analysis that really put things into perspective. According to them, the rheumatoid arthritis market, valued at USD 27.8 billion in 2024, is projected to reach USD 28.8 billion in 2025 and USD 40.1 billion by 2035, representing a CAGR of 3.4% during the forecast period. Rheumatoid Arthritis (RA) is an autoimmune, inflammatory disorder wherein various components of the immune system begin to attack the body’s own cells and tissues. The disease is characterized by pain and swelling in and around the joints. It is a systemic disease and is known to affect several joints at the same time or different joints at different times. Hence, it is also termed as migratory or flitting polyarthritis. It has been estimated that RA affects over 1% of the world population and the overall risk of developing the disease is higher in women as compared to men.

Read More :- https://www.rootsanalysis.com/reports/rheumatoid-arthritis-market/145.html